Li Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Li Sun has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Yongmei Li
Department of Pathogen Biology and Department of Genetics, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China
36 shared publications - Feng Han
Department of Hepatic Biliary Pancreatic Surgery, Cancer Hospital Affiliated to Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan, China
35 shared publications - Hao Zhuang
Department of Hepatobiliopancreatic Surgery The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital Zhengzhou China
35 shared publications - Jianing Huang
Department of Pathogen Biology and Department of Genetics, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China
35 shared publications - Mengya Guo
Department of Pathogen Biology and Department of Genetics, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China
35 shared publications - Minghe Li
Department of Pathogen Biology and Department of Genetics, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China
35 shared publications
Latest Publications
- Open Access
- 3 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (27) , eaeb5510
Rapid evolution of lncRNAs introduces novel regulatory inputs into ancestral cancer pathways
A substantial fraction of human long noncoding RNAs (lncRNAs) are lineage specific and increasingly implicated in cancer, yet the evolutionary origins of their oncogenic relevance remain unclear. It is unknown whether such roles arise through adaptive refinement or as incidental by-products of transcriptomic complexity under weak selection. Here, we show that newly evolved cancer-associated lncRNAs, predominantly of primate origin, arise through a stepwise process initiated by increased transcriptional activity. Once expression surpasses a threshold, these lncRNAs undergo sequence expansion, with 73.3% incorporating external or local genomic fragments, facilitating integration into deeply conserved cancer-related pathways. We validate this model through MIR497HG , which originated near a microRNA in the human-macaque ancestor, and subsequently expanded and integrated into the ancient AMPK (adenosine monophosphate–activated protein kinase)/ferroptosis network in humans, influencing oncogenesis. Collectively, our findings support a model in which weak selection permits neutral transcriptional innovations to persist and gradually infiltrate ancient regulatory architectures, consistent with constructive neutral evolution.
- 3 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (27) , eaeb5510
Open AccessRapid evolution of lncRNAs introduces novel regulatory inputs into ancestral cancer pathways
A substantial fraction of human long noncoding RNAs (lncRNAs) are lineage specific and increasingly implicated in cancer, yet the evolutionary origins of their oncogenic relevance remain unclear. It is unknown whether such roles arise through adaptive refinement or as incidental by-products of transcriptomic complexity under weak selection. Here, we show that newly evolved cancer-associated lncRNAs, predominantly of primate origin, arise through a stepwise process initiated by increased transcriptional activity. Once expression surpasses a threshold, these lncRNAs undergo sequence expansion, with 73.3% incorporating external or local genomic fragments, facilitating integration into deeply conserved cancer-related pathways. We validate this model through MIR497HG , which originated near a microRNA in the human-macaque ancestor, and subsequently expanded and integrated into the ancient AMPK (adenosine monophosphate–activated protein kinase)/ferroptosis network in humans, influencing oncogenesis. Collectively, our findings support a model in which weak selection permits neutral transcriptional innovations to persist and gradually infiltrate ancient regulatory architectures, consistent with constructive neutral evolution.
- Open Access
- 1 March 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from LINC00869 Promotes Hepatocellular Carcinoma Metastasis via Protrusion Formation
Heatmap of enriched lncRNAs binding to WASp and Arp2 protein determined by RIP-seq.
- 1 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from LINC00869 Promotes Hepatocellular Carcinoma Metastasis via Protrusion Formation
Heatmap of enriched lncRNAs binding to WASp and Arp2 protein determined by RIP-seq.
- Open Access
- 1 March 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from LINC00869 Promotes Hepatocellular Carcinoma Metastasis via Protrusion Formation
LINC00869 promotes cell migration, invasion and proliferation in HCC cells.
- 1 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from LINC00869 Promotes Hepatocellular Carcinoma Metastasis via Protrusion Formation
LINC00869 promotes cell migration, invasion and proliferation in HCC cells.
- Open Access
- 1 March 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from LINC00869 Promotes Hepatocellular Carcinoma Metastasis via Protrusion Formation
Summary of the sequencing coverage and quality statistics of the RIP-Seq analysis.
- 1 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from LINC00869 Promotes Hepatocellular Carcinoma Metastasis via Protrusion Formation
Summary of the sequencing coverage and quality statistics of the RIP-Seq analysis.
- Open Access
- 1 March 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from LINC00869 Promotes Hepatocellular Carcinoma Metastasis via Protrusion Formation
Clinicopathological information of HCC specimens for RNA-ISH.
- 1 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from LINC00869 Promotes Hepatocellular Carcinoma Metastasis via Protrusion Formation
Clinicopathological information of HCC specimens for RNA-ISH.
- Open Access
- 1 March 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from LINC00869 Promotes Hepatocellular Carcinoma Metastasis via Protrusion Formation
LINC00869 promotes actin polymerization and protrusion formation.
- 1 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from LINC00869 Promotes Hepatocellular Carcinoma Metastasis via Protrusion Formation
LINC00869 promotes actin polymerization and protrusion formation.
- Open Access
- 1 March 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from LINC00869 Promotes Hepatocellular Carcinoma Metastasis via Protrusion Formation
Sequences of the genes coding shRNA for LINC00869 knockdown experiments.
- 1 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from LINC00869 Promotes Hepatocellular Carcinoma Metastasis via Protrusion Formation
Sequences of the genes coding shRNA for LINC00869 knockdown experiments.
- Open Access
- 1 March 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from LINC00869 Promotes Hepatocellular Carcinoma Metastasis via Protrusion Formation
Sequences of the DNA primers for RT-qPCR and in vitro transcription, and the sequences of LINC00869 probes.
- 1 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from LINC00869 Promotes Hepatocellular Carcinoma Metastasis via Protrusion Formation
Sequences of the DNA primers for RT-qPCR and in vitro transcription, and the sequences of LINC00869 probes.
- Open Access
- 1 March 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from LINC00869 Promotes Hepatocellular Carcinoma Metastasis via Protrusion Formation
LINC00869 promotes cell migration, invasion and proliferation in HCC cells.
- 1 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from LINC00869 Promotes Hepatocellular Carcinoma Metastasis via Protrusion Formation
LINC00869 promotes cell migration, invasion and proliferation in HCC cells.
- Open Access
- 1 March 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from LINC00869 Promotes Hepatocellular Carcinoma Metastasis via Protrusion Formation
Clinicopathological information of the HCC tissue samples for RT-qPCR.
- 1 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from LINC00869 Promotes Hepatocellular Carcinoma Metastasis via Protrusion Formation
Clinicopathological information of the HCC tissue samples for RT-qPCR.